All stock lists
Unlock the score
Charles River Laboratories International, Inc. (New York Stock Exchange:CRL)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
353.86+8.49 (+2.46%)
Insider Score
/ 100
CRL Insider Score
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
CRL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 27, 2026 | Mar 28, 2026 | Dec 27, 2025 | Sep 27, 2025 | Jun 28, 2025 | Mar 29, 2025 |
| Revenue | 1.00 B | 995.83 M | 994.23 M | 1.00 B | 1.03 B | 984.17 M |
| Revenue Growth (YoY) | -2.72 % | 1.18 % | -0.83 % | -0.49 % | 0.59 % | -2.71 % |
| Cost of Revenue | 640.70 M | 716.51 M | 686.37 M | 666.06 M | 675.07 M | 666.44 M |
| Gross Profit | 363.37 M | 279.32 M | 307.86 M | 338.79 M | 357.07 M | 317.73 M |
| SG&A Expense | 228.90 M | 159.42 M | 187.63 M | 177.59 M | 191.55 M | 177.80 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 243.49 M | 159.42 M | 187.63 M | 204.99 M | 256.93 M | 243.06 M |
| Operating Income | 119.89 M | 119.90 M | 120.22 M | 133.80 M | 100.13 M | 74.67 M |
| Pretax Income | 53.17 M | -29.94 M | -294.10 M | 87.20 M | 71.42 M | 35.98 M |
| Tax Provision | 53.93 M | -15.14 M | -17.81 M | 31.64 M | 18.73 M | 10.10 M |
| Net Income | -1.48 M | -14.84 M | -276.56 M | 54.42 M | 52.33 M | 25.47 M |
| EPS (Basic) | -0.03 | -0.30 | -5.62 | 1.11 | 1.06 | 0.50 |
| EPS (Diluted) | -0.03 | -0.30 | -5.62 | 1.10 | 1.06 | 0.50 |
| Shares Outstanding | 48.49 M | 48.95 M | 49.22 M | 49.21 M | 49.15 M | 50.68 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.